Drug · DIN 00115630
LIBRAX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 11, 2019; first marketed December 31, 1961.
- Drug Identification Number (DIN)
- 00115630
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Targeted substances (cdsa iv)
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Clidinium and psycholeptics A03CA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CHLORDIAZEPOXIDE HYDROCHLORIDE | 5 MG | |
| CLIDINIUM BROMIDE | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2019: NOC 22273New Drug Submission (NDS) · Change in product ownership
- September 28, 2004: NOC 5541New Drug Submission (NDS) · Manufacturer name change